Knowledge Center

Patent / Jan 11, 2024

Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation

Authors:
  • Beatriz Fernandes
  • Filipe Vultos
  • Eunice Costa
Source:
WO 2024009079 A1

The present invention describes a dry powder inhaler pharmaceutical composition comprising one or more active pharmaceutical ingredients (API) coated with one or more force control agents (FCA) with optimized aerodynamic performance by micronizing crystalline API particles to the respirable range and coating the particles with a force control agent. The present invention also id pharmaceutical composition, and its use in medicine.

听

Also in the Knowledge Center

Related Content

HPAPI 鈥 Highly Potent API

Our service for HPAPIs ranges from Drug Substance to Particle Engineering.

Page
Read more

Inspections History

四色AV sites are periodically inspected by the local and external authorities. All sites are FDA approved and with exception of New Jersey site all have EU GMP certificates.

Page
Read more

Continuous Tableting for Drug Product

四色AV麓s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.

Page
Read more